Markets

Infinity Pharmaceuticals Inc. (INFI) Enters Overbought Territory - Tale of the Tape

An image of stock prices rising and declining in value
Credit: Shutterstock photo

Infinity Pharmaceuticals Inc. ( INFI ) has moved higher as of late, but there could definitely be trouble on the horizon for this company. That is because INFI is now in overbought territory with an RSI value of 72.49. Furthermore, estimates for the Infinity Pharmaceuticals have been coming down, pushing it to a Zacks Rank #4 (Sell). This suggests that investors may better off exiting this stock before it falls back to Earth.

INFINITY PHARMA (INFI): Free Stock Analysis Report

To read this article on Zacks.com click here.

Zacks Investment Research

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.


The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

In This Story

INFI

Other Topics

Investing Stocks

Latest Markets Videos